Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty

被引:3
|
作者
Chen, Tao [1 ,2 ]
Yu, Wenquan [1 ,2 ]
Xie, Xiaoling [1 ,2 ]
Ge, Huaizhi [1 ,2 ]
Fu, Yuchuan [1 ,2 ]
Yang, Di [1 ,2 ,3 ]
Zhou, Lu [1 ,2 ,4 ]
Liu, Xiaozheng [1 ,2 ]
Yan, Zhihan [1 ,2 ]
机构
[1] Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China
[3] Zhejiang Hosp, Dept Radiol, Hangzhou, Peoples R China
[4] Zhejiang Univ, Childrens Hosp, Dept Radiol, Sch Med, Hangzhou, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
gonadotropin-releasing hormone agonists; idiopathic central precocious puberty; hypothalamic-pituitary-gonadal (HPG) axis; luteinizing hormone; functional magnetic resonance imaging; voxel-mirrored homotopic connectivity; WORKING-MEMORY; SEX-DIFFERENCES; LEUPROLIDE ACETATE; HUMAN BRAIN; SUPPRESSION; ESTROGEN; DIAGNOSIS; RECEPTOR; GNRHA;
D O I
10.3389/fneur.2020.00017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: The pubertal growth suppressive effects of gonadotropin hormone releasing hormone agonists (GnRHa) are well-known, although it remains unclear if long-term GnRHa treatment influences the brain function of treated children. The present study investigated the differences in the homotopic resting-state functional connectivity patterns in girls with idiopathic central precocious puberty (ICPP) with and without GnRHa treatment using voxel-mirrored homotopic connectivity (VMHC). Methods: Eighteen girls with ICPP who underwent 12 months of GnRHa treatment, 40 treatment-naive girls with ICPP, and 19 age-matched girls with premature thelarche underwent resting-state functional magnetic resonance imaging using a 3T MRI. VMHC method was performed to explore the differences in the resting-state interhemispheric functional connectivity. The levels of serum pubertal hormones, including luteinizing hormone (LH), follicular-stimulating hormone, and estradiol, were assessed. Correlation analyses among the results of clinical laboratory examinations, neuropsychological scales, and VMHC values of different brain regions were performed with the data of the GnRHa treated group. Results: Significant decreases in VMHC of the lingual, calcarine, superior temporal, and middle frontal gyri were identified in the untreated group, compared with the control group. Medicated patients showed decreased VMHC in the superior temporal gyrus, when compared with the controls. Compared to the unmedicated group, the medicated group showed a significant increase in VMHC in the calcarine and middle occipital gyrus. Moreover, a positive correlation was observed between basal LH levels and VMHC of the middle occipital gyrus in medicated patients. Conclusions: These findings indicate that long-term treatment with GnRHa was associated with increased interhemispheric functional connectivity within several areas responsible for memory and visual process in patients with ICPP. Higher interhemispheric functional connectivity in the middle occipital gyrus was related to higher basal LH production in the girls who underwent treatment. The present study adds to the growing body of research associated with the effects of GnRHa on brain function.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] GONADOTROPIN-RELEASING-HORMONE AGONISTS IN THE TREATMENT OF GIRLS WITH CENTRAL PRECOCIOUS PUBERTY
    BREYER, P
    HAIDER, A
    PESCOVITZ, OH
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1993, 36 (03): : 764 - 772
  • [2] Idiopathic scoliosis in girls with central precocious puberty: Incidence and effect of gonadotropin-releasing hormone agonists
    Chung, Lindsey Yoojin
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Huh, Rimm
    Lee, Kee-Hyoung
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 262 - 262
  • [3] THE INFLUENCE OF GONADOTROPIN-RELEASING HORMONE AGONISTS ON BODY MASS INDEX IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY
    Lee, Jieun
    Kim, Jae Hyun
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 179 - 180
  • [4] Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
    Shi, Yuzhen
    Ma, Ziyi
    Yang, Xi
    Ying, Yanqin
    Luo, Xiaoping
    Hou, Ling
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [5] The Relationship of Gonadotropin-releasing Hormone Agonists and Anthropometric Indices of Girls with Premature Idiopathic Central Precocious Puberty: A Cohort Study
    Badpeyma, Mohaddeseh
    Molani-Gol, Roghayeh
    Sistanian, Fatemeh
    Khadem-Rezaiyan, Majid
    Eshraghi, Peyman
    Samaei, Fateme
    Faghfouri, Amir Hossein
    Vakili, Rahim
    IRANIAN JOURNAL OF NEONATOLOGY, 2024, 15 (04) : 10 - 16
  • [6] Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
    Chung, Lindsey Yoojin
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Huh, Rimm
    Lee, Kee-Hyoung
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 25 (02) : 92 - 96
  • [7] Growth Outcome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-releasing Hormone Agonist
    Lee, Hae Sang
    Hwang, Jin Soon
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 431 - 432
  • [8] Treatment of Central Precocious Puberty Using Gonadotropin-releasing Hormone Agonists
    Cafasso, Mandi
    Elder, Deborah A.
    Blum, Samantha
    Weis, Tammy
    Hornung, Lindsey
    Khoury, Jane C.
    Stenger, Peggy J.
    Rose, Susan R.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (07): : 686 - 694
  • [9] Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
    Lee, Hae Sang
    Yoon, Jong Seo
    Park, Kyu Jung
    Hwang, Jin Soon
    PLOS ONE, 2018, 13 (08):
  • [10] Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone
    Vottero, A
    Pedori, S
    Verna, M
    Pagano, B
    Cappa, M
    Loche, S
    Bernasconi, S
    Ghizzoni, L
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04): : 1284 - 1287